🟢 Eupraxia Pharmaceuticals is trading 12.33% up in after-hours trading as Nasdaq Composite gains 1.24%

Eupraxia Pharmaceuticals is trading 12.33% up at $7.56 amid broader risk-on sentiment, with major U.S. indices finishing higher.

• It closed at $6.73 on August 21, 2026.
• No new company-specific announcement was identified on August 21.
• The latest notable developments were August 11 financial results and August 13 RESOLVE trial data, making a fresh company catalyst unlikely.